DUBLIN–(BUSINESS WIRE)–The “Dental Practice Management Software Market Research Report by Deployment (Cloud-based and On-premise), Application, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The United States Dental Practice Management Software Market size was estimated at USD 127.07 million in 2021, USD 146.55 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 11.72% to reach USD 247.16 million by 2027.
Market Segmentation & Coverage:
This research report categorizes the Dental Practice Management Software to forecast the revenues and analyze the trends in each of the following sub-markets:
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
6. Dental Practice Management Software Market, by Deployment
6.1. Introduction
6.2. Cloud-based
6.3. On-premise
7. Dental Practice Management Software Market, by Application
7.1. Introduction
7.2. Clinical Applications
7.3. Insurance and Claim Tools
7.4. Patient Management & Billing
8. California Dental Practice Management Software Market
9. Florida Dental Practice Management Software Market
10. Illinois Dental Practice Management Software Market
11. New York Dental Practice Management Software Market
12. Ohio Dental Practice Management Software Market
13. Pennsylvania Dental Practice Management Software Market
14. Texas Dental Practice Management Software Market
15. Competitive Landscape
16. Company Usability Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/j52mj4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic…
The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the…
Remote monitoring reduces office visit and treatment burden in some patientsManassas, Virginia--(Newsfile Corp. - June…
Discussions to focus on constructively bridging the tension of usability, privacy, security, and identity WASHINGTON,…
ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or…
The Executives Will Support the Company with Deep Expertise Across Entertainment, Development and Distribution JUPITER,…